
Sign up to save your podcasts
Or


Todd Harris, CEO of Tyra Biosciences, shares his insights about leadership in biopharma and how Tyra is working to develop precision medicines that target large fibroblast growth factor receptor biology.
By John Simboli5
77 ratings
Todd Harris, CEO of Tyra Biosciences, shares his insights about leadership in biopharma and how Tyra is working to develop precision medicines that target large fibroblast growth factor receptor biology.

534 Listeners

3,072 Listeners

1,091 Listeners

940 Listeners

795 Listeners

125 Listeners

322 Listeners

96 Listeners

9,942 Listeners

34 Listeners

519 Listeners

146 Listeners

349 Listeners

182 Listeners

467 Listeners